PHOTO
- Advances in technology can significantly help not only save lives but also minimize the invasiveness of cardiac procedures.
- The Heart Navigator System and the Dynamic Road Map feature are only available in the cath lab at Rashid Hospital in the Middle East.
- The cardiology department is the second busiest unit in the hospital after the Emergency and Trauma Centre.
- Out of the total admissions in the cardiology department, 50 to 60 per cent of the procedures are performed in the cath lab (non-surgical methods).
- Of all the coronary angiography procedures performed, today almost 80 per cent are treated in the cath lab as opposed to open-heart surgery.
- More than 1,900 patients underwent cath procedures at Rashid Hospital in 2017.
- Al Qutami also inaugurated the second smart pharmacy for the Emergency and Trauma Centre at the hospital.
UAE, Dubai: Rashid Hospital, the biggest hospital in the emirate, became the first in the Middle East to introduce a state-of-the-art catherization laboratory (cath lab).
The highly specialised system has two procedure rooms, a Hybrid and a Biplane lab, that boasts of cutting-edge features and has a calm and stimulating environment to ease patients’ anxiety.
The addition of multiple coloured lights, naturistic pictures on the walls and ceilings help create a relaxing environment especially since cath procedures take place under local anaesthesia and patients are alert and aware of their surroundings.
Given the high volume of cardiovascular cases the hospital receives, the advanced lab will benefit a significant number of patients. The cardiology department is the second busiest at the hospital after the Emergency and Trauma Centre. In 2017, more than 1,900 patients underwent cath procedures including pacemaker installation, coronary angiogram, coronary angioplasty with stenting, and TAVI.
Globally, cardiovascular disease is the number one cause of death and according to some studies; in the Middle-East heart attacks take place approximately ten years earlier than in many western countries.
His Excellency Humaid Al Qutami, Director-General of the Dubai Health Authority, said, “Life-saving procedures are a priority and we will continue to invest in technology, manpower and management systems to provide the highest quality of care to our patients. The introduction of this technology will directly benefit patient-outcomes and experience.”
Dr Fahd Baslaib, CEO of Rashid Hospital and head of cardiology said, “The hybrid catherization system combines both catherization and surgical procedures so that if there is an emergency we can immediately switch from the minimally invasive procedure to a surgical one in the same location almost immediately. This saves time, which is critical in such cases, and ensures quicker patient recovery. Even in non-critical cases, the system is highly beneficial as we can perform different procedures one after the other. This eliminates the need to transfer patients, reduces the waiting time between two procedures and ensures quicker patient recovery.”
He added that the Biplane cath lab is equipped with an electrophysiology system to do ablation procedures.
Reduction in radiation by 60 to 80 per cent:
Dr Baslaib said, “As cath procedures become common and thus more complex, they often require longer imaging time and thus the amount of radiation exposure for healthcare professionals and patients is increasing. This cath lab uses 60 to 80 per cent lesser radiation without affecting the resolution of images, which is a major advantage.”
Reduction in the use of contrast dye:
Dr Baslaib said, “The Biplane system can produce two images at the same time with a single contrast injection. Thus, patients need less contrast dye, which is particularly important for patients with comorbidities such as kidney disease.”
Advanced Imaging and Heart Navigation System:
Dr Baslaib said that the cath lab provides 3-D images in real time and has enhanced visibility features such as live imaging and navigation.
“The Heart Navigator System and the Dynamic Road Map are extremely useful features for interventionists to perform complex procedures with utmost precision. These two features are only available in the cath lab at Rashid Hospital in the Middle East. They are particularly beneficial for complex catheter and ablation techniques that require advanced imaging and accurate navigation inside vessels.”
Third DHA smart pharmacy inaugurated:
After the tour of the cath lab, Al Qutami also inaugurated the third DHA smart pharmacy.
The pharmacy is for the Emergency and Trauma Centre at Rashid hospital and uses a robot for dispensing and prescribing medication. DHA also has another smart pharmacy at Rashid Hospital and one at Dubai Hospital.
Al Qutami said, “In line with our aim to foster the use of smart technology, we will expand smart pharmacies to all DHA hospitals.”
Dr Ali Al Sayed, Director of Pharmaceutical Services Department at DHA said, “The smart pharmacy uses a robot that can store up to 35,000 medicines and dispenses around 11 prescriptions in less than one minute. This greatly enhances efficiency and reduces patient wait times.”
Dr Al Sayed said the robot dispensing process is paper free as the robot stores the prescription as soon as the doctor documents it electronically.
He added that depending on the robot to dispense the medication allows the pharmacist to focus on giving customers the correct instructions on taking the medication.
-Ends-
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance is the President of the DHA and His Excellency Humaid Mohammed Obaid Al Qutami is the Director-General of the DHA.
The DHA’s aim in Dubai is to provide an accessible, effective and integrated healthcare system, protect public health and improve the quality of life within the Emirate. This is a direct translation of the objectives of the Dubai Strategic Plan 2015 launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum. Keeping the strategic plan in mind, the DHA’s mission is to ensure access to health services, maintain and improve the quality of these services, improve the health status of nationals, residents and visitors and oversee a dynamic, efficient and innovative health sector.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including hospitals (Latifa, Dubai, Rashid and Hatta), specialty centres (e.g. the Dubai Diabetes Center) and DHA primary health centres spread throughout the Emirate of Dubai.
The main pillars of service delivery at DHA health facilities are quality, efficiency, patients and staff. It is our aim to maintain and improve the quality and efficiency of DHA health services. An important aspect of the service delivery strategy is to focus on patients, their needs and satisfaction as well as attract, retain, nurture and support outstanding staff.
Prior to the establishment of the DHA, the Department of Health and Medical Services (DOHMS), which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
About UAE GDA
The UAE Genetics Diseases Association was founded in 2004 under the patronage HE Sheikh Nahyan Bin Mubarak Al Nahyan, Cabinet Minister and Minister of Tolerance, United Arab Emirates and President of UAE Genetic Disease Association.
Dr Maryam Matar is the founder and Board director of UAE GDA.
The mission of UAE GDA is to strive to reduce the prevalence and impact of common genetic disorders in the UAE through preventive awareness and screening programs and research conducted by experts in the field using the most innovative technology at the lowest costs.
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
